Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

NCT03285802 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cancer

Interventions

DRUG: Letrozole
DRUG: Everolimus

Sponsor

Greater Baltimore Medical Center